Innocan Pharma (INNPF, $0.08) was a top loser over the last three months, falling -9 to $0.08 per share. A.I.dvisor analyzed 204 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 20, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.